我们曾报道第二代磺脲类降糖药——达美康除有降低糖尿病患者血糖的作用外,还具有减低血小板粘附和ADP诱导血小板聚集的作用。但对目前临床广泛应用的优降糖的抗血小板作用,国外报告不一,国内尚未见同类报告。为了解优降糖是否与达美康同样具有抗血小板功能的作用,及其在 We have reported that the second generation sulfonylurea hypoglycemic agents - in addition to lowering blood glucose in patients with diabetes mellitus role, but also has the effect of reducing platelet adhesion and ADP-induced platelet aggregation. However, the antiplatelet effect of glyburide widely used in clinic at present has different foreign reports and no similar reports have been reported in China. To understand whether hypoglycemic and Deltamex also have anti-platelet function, and its role in